Stocks
Bruker Corporation Financial Statements (BRKR) |
||||||||||
| Bruker Corporationsmart-lab.ru | % | 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 30.12.2022 | 31.12.2022 | 01.03.2023 | 31.12.2023 | 29.02.2024 | 05.11.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 2 531 | 2 531 | 2 531 | 2 965 | 2 965 | 3 188 | |||
| Operating Income, bln rub | 432.7 | 432.7 | 456.0 | 442.9 | 436.9 | 229.1 | ||||
| EBITDA, bln rub | ? | 519.8 | 545.3 | 517.9 | 557.8 | 599.0 | 407.2 | |||
| Net profit, bln rub | ? | 296.6 | 296.6 | 296.6 | 427.2 | 427.2 | 107.0 | |||
| OCF, bln rub | ? | 262.0 | 262.0 | 274.4 | 350.1 | 350.1 | 61.3 | |||
| CAPEX, bln rub | ? | 119.0 | 119.0 | 129.2 | 106.9 | 106.9 | 78.6 | |||
| FCF, bln rub | ? | 143.0 | 143.0 | 145.2 | 243.2 | 243.2 | -17.3 | |||
| Dividend payout, bln rub | 29.8 | 29.8 | 29.8 | 29.4 | 29.4 | 22.6 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 10.0% | 10.0% | 10.0% | 6.88% | 6.88% | 21.1% | ||||
| OPEX, bln rub | 873.0 | 843.3 | 849.7 | 1 054 | 1 076 | 1 312 | ||||
| Cost of production, bln rub | 1 225 | 1 225 | 1 225 | 1 468 | 1 448 | 1 647 | ||||
| R&D, bln rub | 235.9 | 235.9 | 235.9 | 294.8 | 294.8 | 364.3 | ||||
| Interest expenses, bln rub | 18.8 | 16.1 | 16.1 | 36.8 | 16.4 | 58.3 | ||||
| Assets, bln rub | 3 619 | 3 619 | 3 612 | 4 239 | 4 250 | 6 113 | ||||
| Net Assets, bln rub | ? | 1 126 | 1 126 | 1 114 | 1 395 | 1 377 | 1 825 | |||
| Debt, bln rub | 1 219 | 1 219 | 1 270 | 1 282 | 1 380 | 2 297 | ||||
| Cash, bln rub | 645.5 | 645.5 | 645.5 | 488.3 | 488.3 | 148.1 | ||||
| Net debt, bln rub | 573.7 | 573.7 | 624.9 | 793.2 | 891.3 | 2 149 | ||||
| Ordinary share price, rub | 68.4 | 68.4 | 68.4 | 73.5 | 73.5 | 56.4 | ||||
| Number of ordinary shares, mln | 148.6 | 148.6 | 148.6 | 147.2 | 146.4 | 148.1 | ||||
| Market cap, bln rub | 10 157 | 10 157 | 10 157 | 10 816 | 10 757 | 8 351 | ||||
| EV, bln rub | ? | 10 731 | 10 731 | 10 782 | 11 609 | 11 649 | 10 501 | |||
| Book value, bln rub | 1 126 | 397 | 385 | 1 395 | 464 | -676 | ||||
| EPS, rub | ? | 2.00 | 2.00 | 2.00 | 2.90 | 2.92 | 0.72 | |||
| FCF/share, rub | 0.96 | 0.96 | 0.98 | 1.65 | 1.66 | -0.12 | ||||
| BV/share, rub | 7.58 | 2.67 | 2.59 | 9.47 | 3.17 | -4.56 | ||||
| EBITDA margin, % | ? | 20.5% | 21.5% | 20.5% | 18.8% | 20.2% | 12.8% | |||
| Net margin, % | ? | 11.7% | 11.7% | 11.7% | 14.4% | 14.4% | 3.36% | |||
| FCF yield, % | ? | 1.41% | 1.41% | 1.43% | 2.25% | 2.26% | -0.21% | |||
| ROE, % | ? | 26.3% | 26.3% | 26.6% | 30.6% | 31.0% | 5.86% | |||
| ROA, % | ? | 8.20% | 8.20% | 8.21% | 10.1% | 10.1% | 1.75% | |||
| P/E | ? | 34.2 | 34.2 | 34.2 | 25.3 | 25.2 | 78.1 | |||
| P/FCF | 71.0 | 71.0 | 70.0 | 44.5 | 44.2 | -482.7 | ||||
| P/S | ? | 4.01 | 4.01 | 4.01 | 3.65 | 3.63 | 2.62 | |||
| P/BV | ? | 9.02 | 25.6 | 26.4 | 7.76 | 23.2 | -12.4 | |||
| EV/EBITDA | ? | 20.6 | 19.7 | 20.8 | 20.8 | 19.4 | 25.8 | |||
| Debt/EBITDA | 1.10 | 1.05 | 1.21 | 1.42 | 1.49 | 5.28 | ||||
| R&D/CAPEX, % | 198.2% | 198.2% | 182.6% | 275.8% | 275.8% | 463.5% | ||||
| CAPEX/Revenue, % | 4.70% | 4.70% | 5.11% | 3.61% | 3.61% | 2.47% | ||||
| Bruker Corporation shareholders | ||||||||||
